Clinical trials
Terminated Disease Progression trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Weill Medical College of Cornell University | 2 |
| Biomea Fusion Inc. | 1 |
| GlaxoSmithKline | 1 |
| Indiana University | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Pfizer | 1 |
| ThromboGenics | 1 |
| University of California, San Francisco | 1 |
| University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease Progression | 14 |
| Glioma | 3 |
| Brain Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Neoplasms | 2 |
| Anemia | 1 |
| Anemia, Iron-Deficiency | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.